WARSAW, Ind., Jan 18, 2005 /PRNewswire-FirstCall via COMTEX/ -- Zimmer Holdings, Inc. (NYSE: ZMH) announced today that its corporate website, http://www.zimmer.com , has been enhanced to provide easier access for patients seeking information about orthopaedic conditions and treatments and for physicians searching for product data, educational services and surgical techniques. The site has added content about Zimmer Minimally Invasive Solutions(TM) (MIS(TM)) Procedures and Technologies.
"Our Internet presence has been a key element in our drive to link patients and surgeons to the information they need, and then to link patients to the surgeons who can provide necessary treatments," said Zimmer Chairman, President and Chief Executive Officer Ray Elliott. "We have integrated content from the former Centerpulse website into zimmer.com , providing site visitors with even more access to information about arthritis, treatment options, and product solutions."
In addition to streamlined navigation, the website also features greater resources for surgeons, including a calendar of medical education courses and CME webcasts. Product information, surgical techniques, white papers, design rationales, and study guides are available for surgeons who register online. Additional patient education materials have been added, with more than 40 new articles about anatomy, arthritis, back pain, dental implants, and orthopaedic treatments. Patient information on the zimmer.com site has been reviewed for accuracy by surgeons.
In addition to professional and patient education, the site features updated career and investor relations sections.
About the Company
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer is the worldwide #1 pure-play orthopaedic leader in the design, development, manufacture and marketing of reconstructive and spinal implants, trauma and related orthopaedic surgical products. In October 2003, the Company finalized its acquisition of Centerpulse AG, a Switzerland-based orthopaedics company and the leader in the European reconstructive market. The new Zimmer has operations in more than 24 countries around the world and sells products in more than 80 countries. As a result of the acquisition of Centerpulse, reported 2003 sales were $1.9 billion. Full-year 2003 pro forma worldwide sales of Zimmer and Centerpulse were approximately $2.6 billion. The new Zimmer is supported by the efforts of more than 6,500 employees.
Visit Zimmer on the worldwide web at http://www.zimmer.com
Zimmer Safe Harbor Statement
This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 based on current expectations, estimates, forecasts and projections about the orthopaedics industry, management's beliefs and assumptions made by management. Forward-looking statements may be identified by the use of forward-looking terms such as "may," "will," "expects," "believes," "anticipates," "plans," "estimates," "projects," "targets," "forecasts," and "seeks" or the negative of such terms or other variations on such terms or comparable terminology. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that could cause actual outcomes and results to differ materially. These risks and uncertainties include, but are not limited to, our ability to successfully integrate Centerpulse AG and Implex Corp., the outcome of the pending informal SEC investigation of Centerpulse accounting, price and product competition, rapid technological development, demographic changes, dependence on new product development, the mix of our products and services, supply and prices of raw materials and products, customer demand for our products and services, control of costs and expenses, our ability to form and implement alliances, international growth, governmental laws and regulations affecting our U.S. and international businesses, including tax obligations and risks, product liability and intellectual property litigation losses, reimbursement levels from third-party payors, general industry and market conditions and growth rates and general domestic and international economic conditions including interest rate and currency exchange rate fluctuations. For a further list and description of such risks and uncertainties, see the disclosure materials filed by Zimmer with the U.S. Securities and Exchange Commission. Zimmer disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Readers of this document are cautioned not to place undue reliance on these forward-looking statements, since, while we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement is applicable to all forward-looking statements contained in this document.
SOURCE Zimmer Holdings, Inc.
Media: Brad Bishop, +1-574-372-4291, firstname.lastname@example.org , Investors: Marc Ostermann, +1-574-371-8515, email@example.com , or Sam Leno, +1-574-372-4790 firstname.lastname@example.org , all of Zimmer Holdings, Inc.
Copyright (C) 2005 PR Newswire. All rights reserved.
News Provided by COMTEX